Pressure BioSciences, Inc. (PBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0012
0.00 (0.00%)
Jun 15, 2026, 9:30 AM EST
Pressure BioSciences Earnings Call Transcripts
Fiscal Year 2024
-
Relocation to a new manufacturing facility has improved efficiency and reduced costs, despite causing filing delays. The company is launching a joint venture program, starting with Vita Forte, to accelerate commercialization of UltraShear-based products in nutraceuticals, skincare, and nootropics, with several product launches expected in the second half of 2024.